Natco Pharma successfully concludes USFDA inspection of its pharma division unit at Kothur

Natco Pharma announced that on conclusion of the USFDA inspection, it has received Establishment Inspection Report (EIR) classifying the company's pharma division located at Kothur, Hyderabad as Voluntary Action Indicated (VAI).

Powered by Capital Market - Live News